Egalet Stock Analysis (NASDAQ:EGLT)

Add to My Stocks
$5.1 $0.17 (3.45%) EGLT stock closing price Feb 27, 2017 (Closing)
Watch Robo Advisor Video of EGLT Stock Analysis
Egalet
Updated on : Feb 27, 2017
previous close
EGLT 5.1 (0%)
S&P 500 2369.8 (0%)
Closing Price On: Feb 27, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Drugs
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q3
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-228.1%
Sector Average:
-1.1%
5 Quarter Net Profit
Net Margins
2016-Q3
%
LTM Margin
Debt/Equity Ratio
Debt:
82.2M
Debt/Equity Ratio:
 3.22
Compared to the industry
Cash Flow
Operating cash flow:
-$21.1M
Net Income:
-$26.9M
PROS      CONS
Recent Growth
Operating Margins
Net Margins
High Debt Burden
ROIC
ROE
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
PE: N/A
EGLT PS :
4.1
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
-6326.9%
Return on Equity:
-113.7%
Free Cash Flow Margin:
-508.1%
Double Tap To Exit Full Screen
0:00
/

Egalet Analysis Video

79 5 2

View Egalet stock analysis video. This is our EGLT analyst opinion covering the buy and sell arguments for EGLT stock.

Egalet Corp Stock Rating (2.1/5)

Our Egalet stock opinion is based on fundamentals of the company. This Egalet stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy EGLT stock?

  • Egalet sales grew by 178.7% year on year in 2016 Q3.

Should you sell EGLT stock?

  • Egalet reported an average operating margin of -228.1% over the Last Twelve Months (LTM).
  • Over the last 12 months, Egalet had an average Net loss of -251.9%.
  • Egalet has a debt/equity ratio of  3.22, which is worse than the average in the Medical sector.
  • The company does not have profits. Hence the PE ratio is meaningless for EGLT stock.
  • The company has a negative Return on Invested Capital of -6326.9%, which is a red flag.
  • A negative ROE of -113.7% indicates that the company is not able to generate profits with the money shareholders have invested.
  • The company has negative Free Cash Flows (FCF), with a negative FCF margin of -508.1%.

Comments on this video and Egalet stock